---
DrugClass: "[[Cholinergic Blocking Drugs]]"
SubClass: "[[Cholinergic Blocking Drugs for Parkinson Disease]]"
DrugClassContra: "[[Cholinergic Blocking Drugs#Contraindications]]"
DrugClassAdverse: "[[Cholinergic Blocking Drugs#Side/Adverse Effects]]"
SecondaryDrugClass: "[[Antiparkinson]]"
SecondarySubClass: "[[Cholinergic Blocking Drugs (Anticholinergics)]]"
BrandName: 
Chapter: "26"
KindleLinkChap: "[Chapter 26](kindle://book?action=open&asin=B09FRF11YJ&location=13703)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
---
```smiles
C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
Parkinsonism symptoms, drug-induced [[EPS]]
1â€“ 15 mg/ day orally in divided doses

### Contraindications
See `= this.DrugClassContra`

### Interactionsts
See `= this.DrugClassAdverse`
Same as [[benztropine mesylate#Side/Adverse Effects]]

### Interactions

`= this.ChemLink+this.file.name`

